Biosimilars represent an opportunity to improve access and affordability for our community. Univera Healthcare has advocated for the use of biosimilars since 2018 when we were the first standalone health plan to prefer a biosimilar in a major drug category. Today we include biosimilars in all drug categories in which biosimilars are available.

To improve account security, multi-factor authentication (MFA) will be enabled toward the end of October.

Updates for Standalone dental single contract groups and change in AGIF Mailing process.